Approval · Notice of Compliance 1356 · 2000
ANANDRON: Notice of Compliance 1356
Issued January 5, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1356
- Date
- January 5, 2000
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength 150mg
- Therapeutic class
- Nonsteroidal antiandrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANANDRON | 02241376 | — |
Medicinal ingredients
- NILUTAMIDE 150 MG per TAB